SCHEMBL4862366

SCHEMBL4862366

Cc1ccc(N=C(N)c2ccccn2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.57
RAB9A P51151 10/20 0.57
PKM P14618 6/20 0.57
CDK5 Q00535 4/20 0.57
CDK5R1 Q15078 4/20 0.57
KMT2A Q03164 1/20 0.57
PAX8 Q06710 1/20 0.57
NOS3 P29474 2/20 0.55
NOS1 P29475 2/20 0.55
NOS2 P35228 2/20 0.55
CYP2D6 P10635 1/20 0.53
HIF1A Q16665 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KLF5 Q13887 2/20 0.49
TNF P01375 1/20 0.49
NOD1 Q9Y239 1/20 0.49
HTR3E A5X5Y0 1/20 0.48
SLC22A2 O15244 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854739 0.83 NOS3 (0.55) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL4855895 0.83 RAB9A (0.61) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL4861200 0.83 NOS3 (0.58) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL4860972 0.83 NOS1 (0.58) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL5594064 0.80 KDM4E (0.50) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL22044263 0.79 NPC1 (0.63) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL11568392 0.78 AGTR1 (0.49) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL11568396 0.78 AGTR1 (0.49) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL12560610 0.76 KDM4E (0.54) NPC1RAB9APKMCDK5CDK5R1
SCHEMBL834329 0.76 KDM4E (0.54) NPC1RAB9APKMCDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP NPC1 1563/4885RAB9A 2079/4885PKM 692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.